New funding opportunity: Syringe Access Fund

The Syringe Access Fund is a collaborative grantmaking initiative that seeks to reduce the health, psychosocial and socioeconomic disparities experienced by people who use drugs. The Syringe Access Fund invests in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts, and connect people who use drugs to comprehensive prevention, treatment and support services.

The Syringe Access Fund awards grants in two categories: 1) syringe services programs providing direct services, or 2) harm reduction organizations conducting community education and mobilization activities focused on legalizing or strengthening syringe services programs and other health interventions for people who use drugs at the local, state and federal levels. This funding round prioritizes syringe services programs that are led by and serving Black, Indigenous, and other people of color, as well as SSPs in areas of high need, for both direct service and education and mobilization efforts.

The application process for Round 12 begins with the submission of a Letter of Inquiry, due on Nov. 5, 2021, at 5 p.m. EDT. Please find more information, including details on eligibility, process and key dates, in the Request for Letters of Inquiry linked here.

Please feel welcome to reach out to with any questions.

Key Dates:

  • Oct. 18, 2021: Request for Letters of Inquiry Released
  • Nov. 5, 2021: Letters of Inquiry Due
  • Nov. 19, 2021: Organizations Invited to Submit a Full Application
  • Optional office hours: 
    • Wednesday, Oct. 20, 4:00-6:00 p.m. EDT 
    • Wednesday, Oct. 27, 4:00-6:00 p.m. EDT 
    • Wednesday, Nov. 3, 4:00-6:00 p.m. EDT 
  • Technical assistance webinar: Oct. 26, 2021, 4-5 p.m. EDT (To register, click here.)
  • Dec. 17, 2021: Completed Application Due to AIDS United
  • Jan. 14, 2022: Notification of Funding Decision
  • Feb. 1, 2022: Grant Period Begins